Brief: AC Immune Provides Update On Study Evaluating Crenezumab In Autosomal Dominant Alzheimer's Disease

AC Immune SA

16/06/2022 06:04

June 16 (Reuters) - AC Immune SA  ACIU.O :
    * AC IMMUNE PROVIDES UPDATE ON ALZHEIMER’S PREVENTION
INITIATIVE
STUDY EVALUATING CRENEZUMAB IN AUTOSOMAL DOMINANT ALZHEIMER’S
DISEASE
    * AC IMMUNE - CRENEZUMAB DID NOT SLOW OR PREVENT COGNITIVE
DECLINE
IN PEOPLE WITH GENETIC MUTATION WHICH CAUSES EARLY-ONSET
ALZHEIMER'S DISEASE
    * CRENEZUMAB WAS GENERALLY WELL TOLERATED DURING STUDY AND
NO NEW
SAFETY ISSUES WERE IDENTIFIED

Source text for Eikon:  ID:nGNX64TycL 
Further company coverage:  ACIU.O 

 ((Reuters.Briefs@thomsonreuters.com;))